Literature DB >> 26121973

Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.

Stefania Frasson1, Gualberto Gussoni2, Pierpaolo Di Micco3, Raquel Barba4, Laurent Bertoletti5, Manuel J Nuñez6, Beatriz Valero7, Angel Luis Samperiz8, Agustina Rivas9, Manuel Monreal10.   

Abstract

Several risk assessment models include infection and immobility among the items to be considered for venous thromboembolism (VTE) prevention. However, information on patients with infection leading to immobility and developing VTE are limited, as well as on the role of specific types of infection. Data were collected from the worldwide RIETE registry, including patients with symptomatic objectively confirmed VTE, and followed-up for at least 3 months. The overall population of RIETE at June 2013 (n = 47,390) was considered. Acute infection leading to immobility was reported in 3.9 % of non-surgical patients. Compared with patients immobilized due to dementia, patients with infection had a shorter duration of immobilization prior to VTE (less than 4 weeks in 94.2 vs. 25.9 % of cases; p < 0.001). During the 3-month follow-up, VTE patients with infection versus those with dementia had a lower rate of fatal bleeding (0.5 vs. 1.1 %; p < 0.05) or fatal PE (1.7 vs. 3.5 %; p < 0.01). Patients with respiratory tract infections had more likely PE as initial VTE presentation than other types of infection (62.3 vs. 37.7 %; p < 0.001). Significantly more patients with pneumonia than those with other respiratory infections had received VTE prophylaxis (50.2 vs. 30.6 %; p < 0.001). Following VTE, patients with sepsis showed a significantly higher risk of fatal bleeding. Based on our real-world data, infection seems to contribute to the pathogenesis of VTE by accelerating the effects of immobility. Its role as VTE risk factor probably deserves further attention and specific assessment in order to optimize VTE prophylaxis and treatment.

Entities:  

Keywords:  Immobility; Infection; Pneumonia; Venous thromboembolism

Mesh:

Year:  2016        PMID: 26121973     DOI: 10.1007/s11239-015-1242-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  42 in total

1.  Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction?

Authors:  K Bhagat; R Moss; J Collier; P Vallance
Journal:  Cardiovasc Res       Date:  1996-11       Impact factor: 10.787

2.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

3.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

4.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

5.  The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD.

Authors:  Ramsey Sabit; Paul Thomas; Dennis J Shale; Peter Collins; Seamus J Linnane
Journal:  Chest       Date:  2010-02-12       Impact factor: 9.410

6.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

Review 7.  Virchow's triad revisited: abnormal flow.

Authors:  Gordon D O Lowe
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

8.  Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.

Authors:  Frederick A Anderson; Maxim Zayaruzny; John A Heit; Dogan Fidan; Alexander T Cohen
Journal:  Am J Hematol       Date:  2007-09       Impact factor: 10.047

9.  Risk factors and presentation of deep venous thrombosis among Asian patients: a hospital-based case-control study in Singapore.

Authors:  Ker-Kan Tan; Woon-Puay Koh; Alexandre K H Chao
Journal:  Ann Vasc Surg       Date:  2007-02-26       Impact factor: 1.466

10.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

View more
  8 in total

Review 1.  Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians.

Authors:  Eduardo Vazquez-Garza; Carlos Jerjes-Sanchez; Aline Navarrete; Jorge Joya-Harrison; David Rodriguez
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

Review 2.  Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach.

Authors:  Raquel López-Reyes; Grace Oscullo; David Jiménez; Irene Cano; Alberto García-Ortega
Journal:  Arch Bronconeumol       Date:  2020-08-31       Impact factor: 4.872

3.  High Occurrence of Thrombo-Embolic Complications During Long-Term Follow-up After Pleural Infections-A Single-Center Experience with 536 Consecutive Patients Over 17 Years.

Authors:  Henna Maria Ala-Seppälä; Mika Tapani Ukkonen; Antti Ilmari Lehtomäki; Emilia Susanna Pohja; Jaakko Juhani Nieminen; Jari Olavi Laurikka; Jahangir Ari Khan
Journal:  Lung       Date:  2020-06-30       Impact factor: 2.584

4.  Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience.

Authors:  Marco Loffi; Valentina Regazzoni; Marco Toselli; Alberto Cereda; Anna Palmisano; Davide Vignale; Francesco Moroni; Gianluca Pontone; Daniele Andreini; Elisabetta Maria Mancini; Alberto Monello; Gianmarco Iannopollo; Gianni Casella; Francesco Monetti; Lorenzo Monti; Giuseppe Ferrillo; Gaetano Liccardo; Elisabetta Tonet; Ottavio Zucchetti; Alberto Cossu; Marco Dugo; Gianluigi Patelli; Pietro Sergio; Antonio Esposito; Antonio Colombo; Francesco Giannini; Raffaele Piccolo; Gian Battista Danzi
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 5.  Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.

Authors:  Alberto García-Ortega; David de la Rosa; Grace Oscullo; Diego Castillo-Villegas; Raquel López-Reyes; Miguel Ángel Martínez-García
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 3.005

6.  Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review.

Authors:  Mauricio Castillo-Perez; Carlos Jerjes-Sanchez; Alejandra Castro-Varela; Jose Gildardo Paredes-Vazquez; Eduardo Vazquez-Garza; Ray Erick Ramos-Cazares; Jose Alfredo Salinas-Casanova; Abigail Montserrat Molina-Rodriguez; Arturo Adrián Martinez-Ibarra; Mario Alejandro Fabiani; Yoezer Z Flores-Sayavedra; Jaime Alberto Guajardo-Lozano; Hector Lopez-de la Garza; Hector Betancourt-Del Campo; Daniela Martinez-Magallanes; Jathniel Panneflek
Journal:  Thromb J       Date:  2021-12-15

7.  Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiectasis.

Authors:  Qingshan Chen; YongSheng Cai; Zhirong Zhang; Honghong Dong; Jinbai Miao; Hui Li; Bin Hu
Journal:  Thromb J       Date:  2022-08-01

8.  Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study.

Authors:  Alberto Alonso-Fernández; Nuria Toledo-Pons; Borja G Cosío; Aina Millán; Néstor Calvo; Luisa Ramón; Sara Hermoso de Mendoza; Daniel Morell-García; Josep Miquel Bauça-Rossello; Belén Núñez; Jaume Pons; Juan A Palmer; Luisa Martín; María Peñaranda; Joan A Pou; Jaume Sauleda; Ernest Sala-Llinas
Journal:  PLoS One       Date:  2020-08-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.